Dave Bryant
Analyst · Stephen Laws of Raymond James
Thank you, Matt. Good morning. Our GAAP net income allocable to common shares for the three-months ended September 30, 2019 was $10 million or $0.31 per share and $21.8 million or $0.69 per share for the nine-months ended September 30. Core earnings were $9.9 million or $0.31 per share for Q3 2019, or an increase of $1.1 million or 12% over Q2. Core earnings were $26.6 million or $0.84 per share for the nine-months ended September 30, 2019 for an increase of $11.7 million or $79% over the same period in 2018. The growth in our core earnings is being driven primarily by our year-to-date net investment production. Accordingly, we saw net interest income increased by $1 million or 7% as compared to the second quarter of 2019 and by $7.1 million or 18% for the nine-month period over the same time in 2018. We have also seen our general and administrative costs declined by 785,000 or 10% through the same nine month period year-over-year. The growth in our dividends paid for the nine-months represents an increase of 125% over the same nine-month period in 2018. In terms of significant items impacting GAAP earnings, we recovered $1.1 million or $0.04 per share of general loan loss reserves this period. As a result, from the payoffs of four loans with an aggregate balance of $72.6 million, which were risk rated three prior to paying off. In addition, as a result of the increase loan payoffs this period, we recorded additional interest income of $0.05 per share from the acceleration of loan origination and exit fees. This acceleration of fees was partially offset by the accelerated recognition of financing costs of $0.03 per share, which is reflected in interest expense. The net impact was $0.02 with positive net interest income per share during the quarter. GAAP net income adjusted for the reversal of our general reserve and net impact from these onetime fee adjustments would have been $0.25 per share, and core earnings adjusted for the accelerated fees and costs would have been $0.29 per share. GAAP book value increased at September 30, $14.12 per share, common share from June 30 of $14.06, now represents a $0.10 increase from December 31, 2018. We began reporting economical value, a non-GAAP metric at December 31 2018, in an effort to improve consistency and transparency for our shareholders and the analyst community. GAAP book value per common share $14.12 less the adjustment for unamortized discounts on our convertible notes and redemption value of our preferred stock, both totaling $0.41 per share, yields an economic book value of $13.71 per common share at September 30. As a point of comparison, the economic book value at December 31, 2017 was $13.63 per common share and highlights our booked value stability. Our GAAP debt-to-equity ratio declined slightly to 3.4 times at September 30, down from 3.5 times at June 30. Asset-specific debt declined by $48.8 million during the quarter due primarily to redemption of our 2017, that’s CRE5 CLO in July, and second from paydowns on our 2018, that’s CRE6 CLO. Those were offset by a net increase in our CRE term facilities as we financed the portion of our loan pipeline during the period. Stockholders’ equity increased by $2.1 million, as GAAP earnings exceeded our dividend and were offset by a net decrease in our bond and corresponding swap mark-to-market valuations, which is of course reflected in other comprehensive income. As an experienced issuer in the CRE CLO markets having issued nine deals, totaling $3.7 billion of real estate CLO notes since inception, we have now issued and repaid seven CLO financing vehicles totaling $2.5 billion, every investor receiving 100% of their principal and interest payments too. We find the CLO market and attractive source of non mark-to-market cost efficient financing and expect to engage the marketplace when we are ready to launch our next transaction. While we saw a decline in the net deployment this quarter, our trailing 12-month gross production of $1.2 billion, inclusive of the portfolio acquisition and $1 billion excluding the portfolio acquisition is indicative of our lending platforms evolution. Loan payoffs and paydowns were $256.9 million, on loans with the spread of LIBOR plus 4.22% at an average life of 31 months. At September 30, our $1.8 billion floating-rate, commercial real estate loan portfolio at par has a weighted average LIBOR floor of 1.87%, and a weighted average spread over LIBOR of 3.64%. To mitigate the impact of the decline in LIBOR, we have a sparkly included LIBOR floors on our loans along with minimum interest period protection. At the end of September, we had $967 million or 55% of our loan book with floors that are in the money as LIBOR, yet below 2% in early October. We’ll expect to see a benefit to net interest income during the fourth quarter as LIBOR curve projects a further decrease in rate. We have a LIBOR floors and substantially all of our loans, most of which maintain a minimum interest rate protection period of 18-months, and nearly all having at least 12-months of protection at the time of origination. Looking ahead, we expect to redeem the remaining $21 million of our 8% convertible note when they mature in January 2020. And we have sufficient liquidity of $183 million at October 30 to fund that redemption and to continue to fund what is now a robust commercial real estate debt investment pipeline. With that, I’ll turn the call back to Bob for final comments.